Richard Rosenquist Brandell is a Professor and Senior Physician in Clinical Genetics at Karolinska Institutet and Karolinska University Hospital, Stockholm. He also serves as the Director of Genomic Medicine Sweden, a national infrastructure for implementation of precision medicine. By utilising cutting‐edge molecular tools, his research has identified novel prognostic and predictive biomarkers in hematological malignancies, particularly chronic lymphocytic leukemia, thereby improving patient risk stratification and clinical decision-making. Additionally, he has played a key role in the adoption of clinical whole-genome/transcriptome sequencing for patients with acute leukemia. He also serves as co-chair of the newly established Precision Omics Initiative Sweden (PROMISE). Richard Rosenquist Brandell is a member of the Nobel Assembly at Karolinska Institutet.